PROPANC BIOPHARMA, INC.
Asset & Liabilities Breakdown
FY2025
FY2024
FY2023
FY2022
FY2021
FY2020
FY2019
FY2018
FY2017
FY2016
FY2015
FY2014
FY2013
FY2012
FY2011
Asset Breakdown FY2017
Total Assets: $95.1K
Liabilities Breakdown FY2017
Total Liabilities: $5.5M
Asset Breakdown
Total Assets: $95.1K
| Line Item | Value | % of Total |
|---|---|---|
| Cash & Equivalents | $0 | 0.0% |
| Accounts Receivable | $0 | 0.0% |
| Inventory | $0 | 0.0% |
| Property, Plant & Equipment | $10.8K | 11.3% |
| Goodwill | $0 | 0.0% |
| Intangible Assets | $0 | 0.0% |
| Other Assets | $84.3K | 88.7% |
Liabilities Breakdown
Total Liabilities: $5.5M
| Line Item | Value | % of Total |
|---|---|---|
| Accounts Payable | $483.5K | 8.7% |
| Long-Term Debt | $3.5M | 62.8% |
| Other Liabilities | $1.6M | 28.4% |